Sponsor Pipeline

Laekna Limited Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04851613 Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With… Breast Cancer Active, Not Recruiting
Phase 1
NCT06493084 Evaluate LAE102 in Healthy and Overweight/Obese Subjects Overweight and Obese Volunteers Recruiting
NCT07230496 A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in… Overweight and Obesity Recruiting
Disease Areas
Obesity (2) Breast Cancer (1)
Get alerts when Laekna Limited's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free